Evaluating Cardiac Surgery Outcomes for Rheumatic Heart Disease
and Anticoagulant Therapy Quality in Ethiopia and Norway
Led by Helse Nord-Trøndelag HF · Updated on 2025-06-12
200
Participants Needed
4
Research Sites
25 weeks
Total Duration
AI-Summary
What This Trial Is About
This research aims to evaluate cardiac surgery outcomes for people with rheumatic heart disease RHD in Ethiopia, a low-income country. It compares the short- and long-term results of those who receive surgery with individuals who do not, due to limited access to cardiac surgery services. The study also examines the quality of anticoagulant therapy after surgery, assessing complications and treatment effectiveness compared to patients in Norway.
The study observes three groups RHD patients undergoing cardiac surgery at Addis Abeba University Hospital, RHD patients who are not offered surgery, and Norwegian patients receiving anticoagulant therapy after valve replacement. Follow-up lasts 180 days for surgery outcomes, with ongoing monitoring of anticoagulation quality. Researchers look at mortality and complications such as heart failure, arrhythmias, thrombosis, bleeding, stroke, and infections.
Participants will be monitored through clinical assessments and echocardiographic evaluations. The study tracks the time patients spend within therapeutic INR levels and records complications related to valve function and anticoagulant use. Outcome measures focus on short-term results at 180 days and longer-term anticoagulation quality. The study began in 2016 and will continue until 2026, involving matched control groups for comparison.
CONDITIONS
Brief Title
The Clinical Influence of Developing a Sustainable Cardiac Surgery Service to Reduce the Burden of Rheumatic Heart Disease in Sub-Saharan Africa
Research Team
H
Haavard Dalen, MD, PhD
R
Rune Haaverstad, MD, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Cardiac surgery due to rheumatic heart disease at the governmental Black Lion University Hospital during the bi-directional programme of education, training and Research to establish Cardiac surgery service
You will not qualify if you...
Not willing or able to provide written informed consent
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Surgery and Immediate Post-operative Care
Duration - Up to discharge from hospital
Participants undergo cardiac surgery for rheumatic heart disease followed by immediate post-operative care at the hospital.
Hospital stay visits as per routine care
Post-operative Follow-up
Duration - 180 days
Participants are followed for 180 days after surgery to monitor outcomes including mortality and complications such as heart failure, arrhythmias, thrombosis, bleeding, stroke, and infections.
Regular follow-up visits up to 180 days
Long-term Monitoring
Duration - Ongoing beyond 180 days
Participants on anticoagulation therapy are continuously monitored for quality of therapy, including time in therapeutic INR-level and complications.
Visit frequency varies depending on anticoagulation management
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Similar Trials
GOAL-Stop Trial Studying Stopping Versus Continuing Penicillin to Prevent Rheumatic Heart Disease Progression in Children and Teens
Accelerating Delivery of Rheumatic Heart Disease Prevention and Care Services in Northern Uganda
A District-Based Program Using Echocardiography and Registry Follow-up
Randomized Trial Evaluating Anticoagulant Therapy in Atrial Fibrillation Patients After Surgical Left Atrial Appendage Closure
Study Comparing the Safety and Effectiveness of Rivaroxaban 15mg and 20mg in Adults With Non-valvular Atrial Fibrillation
Study of CytoSorb Device Treatment in Adults with Acute on Chronic Liver Failure
Comparing Standard Care Plus CytoSorb to Standard Care Alone
Adapting and Implementing the WHO PEN-Plus Model for Managing Severe Chronic Non-Communicable Diseases at First-Level Hospitals in Zambia
Evaluating a School Nurse Program to Prevent Rheumatic Heart Disease in Children Aged 5 to 16 in Nepal
Korea Nationwide Study on Moderate and Severe Valvular Heart Disease
Using Echocardiographic and Medical Record Data
Insights into Disease Burden and Treatment Patterns
Comparing Low-Dose and Standard-Dose Rivaroxaban for Treating Atrial Fibrillation in Patients Aged 70 and Older
Community and School-Based Screening for Rheumatic Heart Disease in Sindh with Secondary Prevention Treatment and Follow-Up
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Short-term outcome after open-heart surgery for severe chronic rheumatic heart disease in a low-income country, with comparison with an historical control group: an observational study.
Ståle Wågen Hauge, Havard Dalen, Mette E Estensen...